NCT00872820 Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder Status COMPLETED Phase NA
NCT00862212 Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting Status COMPLETED Phase NA
NCT00606541 An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR) Status TERMINATED Phase EARLY_PHASE1
NCT00515879 Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia Status COMPLETED Phase PHASE3
NCT00485615 An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia Status COMPLETED Phase PHASE2
NCT00332046 fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder Status COMPLETED Phase PHASE1
NCT00330174 Acamprosate in Alcoholics With Comorbid Anxiety or Depression Status COMPLETED Phase PHASE4
NCT00302770 Efficacy of Quetiapine in Generalised Social Anxiety Disorder Status TERMINATED Phase PHASE3
NCT00273039 A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder Status COMPLETED Phase PHASE2
NCT00246441 Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism Status COMPLETED Phase PHASE4
NCT00238719 Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder Status COMPLETED Phase PHASE3